American Society of Hematology

SHERPA: Blue

People

  1. Lesokhin
    Lesokhin
  2. Chung
    Chung
  3. Giralt
    Giralt
  4. Hassoun
    Hassoun
  5. Devlin
    Devlin
  6. Landau
    Landau
  7. Korde
    Korde
  8. Dogan
    Dogan
  9. Funt
    Funt
  10. Shah
    Shah

Groups

  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Hematologic Malignancies Research (7)
  4. Hematologic Malignancies, Division of (7)
  5. Myeloma (7)
  6. Bone Marrow Transplant (5)
  7. Biostatistics Service (4)
  8. Epidemiology and Biostatistics (4)
  9. Survivorship Research (4)
  10. Genitourinary Oncology Service (1)
Search Within
  1. "2015"
  2. "Center for Hematologic Malignancies"
  3. "Alexander Lesokhin"
Formats
  1. Meeting Abstract (7)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Hematologic Malignancies Research (7)
  4. Hematologic Malignancies, Division of (7)
  5. Myeloma (7)
  6. Bone Marrow Transplant (5)

More Groups

People
  1. Alexander Lesokhin (7)
  2. Carl Landgren (5)
  3. David Chung (5)
  4. Hani Hassoun (5)
  5. Sergio Giralt (5)
  6. Heather Landau (4)

More People

Years
  1. 2015 (7)
Publications
  1. Blood (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Autologous hematopoietic stem cell transplantation overcomes primary refractory disease in multiple myeloma patients treated with novel agents
    Meeting Abstract

    Shah, G. L.; Hsu, M.; Devlin, S.; Chung, D. J.; Hassoun, H.; Koehne, G.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Continuous treatment with lenalidomide plus low-dose dexamethasone (Ld) versus Ld induction followed by autologous stem cell transplant (ASCT) in patients with newly diagnosed multiple myeloma (NDMM): A pooled analysis of two randomized clinical trials
    Meeting Abstract

    Lentzsch, S.; Villanueva, N.; Nguyen, J.; Landau, H.; Lendvai, N.; Miao, S.; Schecter, J. M.; Reyna, M.; Mapara, M. Y.; Redner, R. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Biomarkers of cardiotoxicity among multiple myeloma patients subsequently treated with proteasome inhibitor therapy
    Meeting Abstract

    Lendvai, N.; Devlin, S.; Patel, M.; Knapp, K. M.; Ekman, D.; Grundberg, I.; Chung, D. J.; Hassoun, H.; Koehne, G.; Lesokhin, A. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The long PD-1 receptor binding kinetics of nivolumab may increase efficacy of subsequent therapy in relapsed and refractory multiple myeloma patients
    Meeting Abstract

    Funt, S. A.; Page, D. B.; Cattry, D.; Lendvai, N.; Hassoun, H.; Landgren, O.; Borrello, I. M.; Lesokhin, A. M.
    Blood (2015)

    Fulltext@MSK | Save
  • T cell exhaustion/senescence in relapsed multiple myeloma after autologous stem cell transplantation
    Meeting Abstract

    Chung, D. J.; Pronschinske, K. B.; Shyer, J. A.; Sharma, S.; Leung, S.; Curran, S. A.; Lesokhin, A. M.; Devlin, S.; Giralt, S. A.; Young, J. W.
    Blood (2015)

    Fulltext@MSK | Save
  • Presence of PD-1 expressing T cells predicts for inferior overall survival in newly diagnosed multiple myeloma
    Meeting Abstract

    Gasmi, B.; Smith, E. L.; Dogan, A.; Hsu, M.; Devlin, S.; Pichardo, J. D.; Chung, D. J.; Koehne, G.; Korde, N. S.; Landau, H. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Nivolumab in patients (Pts) with relapsed or refractory classical Hodgkin lymphoma (R/R cHL): Clinical outcomes from extended follow-up of a phase 1 study (CA209-039)
    Meeting Abstract

    Ansell, S.; Armand, P.; Timmerman, J. M.; Shipp, M. A.; Garelik, M. B. B.; Zhu, L. L.; Lesokhin, A. M.
    Blood (2015)

    Fulltext@MSK | Save